PCL Skin Booster For Face
Ingredient: 1.5% polycaprolactone, 12mg/ml micro crosslinked sodium hyaluronic
Specification: 1ml,2ml
Package: Single package
Application Area: Light lines of the eyes, light lines of the neck, the light lines around the mouth, lying silkworm, etc
Product Introduction:
As a domestically developed and exclusive product, this formula provides a comprehensive solution for both fine-line filling and deep hydration. It comes in 1mL and 2mL options, catering to manual and machine-assisted injections. Its excellent consistency ensures smooth passage through a 32G needle without clogging or aggregation.
Product Display:
Product Details:
Type | PCL Skin Booster |
Ingredient | polycaprolactone, 12mg/ml microcrosslinked sodium hyaluronic |
Specification | 1ml,2ml |
Effect area | Subcutaneous superficial and subcutaneous injection filling |
Application area | Light lines of the eyes, light lines of the neck, the light lines around the mouth, lying silkworm, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 6 months |
Lasting time | 6 months |
Microsphere size | The median particle size was 32±6μm, and more than 95% of the microspheres were between 25 and 50μm |
Extruding force | 15N |
Product Package:
Customer Feedback:
Raw Material Advantages:
Compared to conventional products with a pushing force of 20N, this formulation requires only 12N, ensuring smoother injection and a more comfortable experience for both doctors and patients. Its excellent viscoelasticity allows for effective enhancement of the nasal base, brow arch, and facial contours. The HA content is between 20-24 mg/g, offering a wider range of options and customizable solutions. Different types of microspheres influence degradation time and rate, with PCL microspheres providing longer-lasting effects than block copolymer microspheres. This product is highly versatile and has shown significant improvements in the nose, jawline, tear troughs, temples, and more.
Development Process:
Company Introduction:
Through our specialized synthesis technology, PCL/PLLA is produced with a low tin content (Sn <30 ppm), optimized molecular weight, and medical-grade biocompatibility, using anhydrous, oxygen-free synthesis conditions at a kilogram-scale capacity. Additionally, our purification platform refines industrial-grade raw materials to obtain sterile, pyrogen-free medical-grade substances, including sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.